Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q3 FY2021 Earnings Presentation
16 slides from Neogen Chemicals's earnings presentation, Feb 15, 2021
Slide 1: Q3 & 9M FY21 Earnings Presentation
Neogen Chemicals Ltd. Q3 & 9M FY21 Earnings Presentation February 2021
Slide 2: Safe Harbour
Safe Harbour 2 Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ
Slide 3: Table of Contents
Table of Contents 3 4 6 7 13 14 15 16 30 Introduction Q3 & 9M Historical Competitive Management Way to Neogen FY21 Financial Contact Us Advantages Commentary Forward Chemicals Financial Trends Performance
Slide 4: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance 4 Leading manufacturer of Bromine and Lithium-based specialty chemicals, operating since 1991 Products developed Of workforce in Strong portfolio of Organic and Inorganic products by in-house R&D R&D team Customers across multiple industries including Pharma, Engineeri
Slide 5: Business Overview and Clientele
Business Overview 5 Organic Chemicals Inorganic Chemicals The portfolio includes specialty, inorganic Custom Synthesis & Contract lithium-based chemical products which Bromine Compounds Advanced Intermediates Manufacturing find applications across multiple industries Organic compounds containing Com
Slide 6: Competitive Advantages
Competitive Advantages 6 Large and diverse array of products Strong Manufacturing Capabilities Experienced promoters with domain knowledge Diversified and Stable Established and stable Customer Base relationship with suppliers Specialised Business Model Continuous Investment with high entry barriers
Slide 7: Key Performance Highlights – Q3 & 9M FY21
Key Performance Highlights – Q3 & 9M FY21 7 Q3 FY21 9M FY21 Rs. 85 crore 3.5% Rs. 244 crore 8.9% Revenues Q3 FY21 Revenue break-up Rs. 17 crore 5.3% Rs. 46 crore 8.5% EBITDA *Exports 45% Domestic 55% Rs. 12 crore 3.8% Rs. 31 crore 3.7% Profit Before Tax Rs. 9 crore 3.9% Rs. 22 crore 3.1% *Including
Slide 8: Financial Summary – 9M FY21
Financial Summary – 9M FY21 8 REVENUE EBITDA PAT 45.8 3.1% 22.1 42.2 21.4 243.7 223.8 9M FY20 9M FY21 9M FY20 9M FY21 9M FY20 9M FY21 Rs. crore Rs. crore Rs. crore Sharp recovery in global economic activity led to positive • EBITDA improved despite initial impact of CoVID-19 PAT performance has to b
Slide 9: Revenue break-up – Q3 & 9M FY21
Revenue break-up – Q3 & 9M FY21 9 Q3 FY21 Q3 FY20 9M FY21 9M FY20 1.6% Rs. 69 crore 36%Rs. 70 crore Rs. 202 crore Rs. 182 crore 10.8% Organic Chemicals 36.0% Rs. 16 crore Rs. 12 crore Rs. 42 crore* Rs. 42 crore - Inorganic Chemicals * Revenues in the Inorganic Chemicals segment have been impacted du
Slide 10: Seasonal Variance Factors
Seasonal Variance Factors 10 • Neogen’s business has some seasonal drivers, due to which the company tends to deliver stronger financial performance in the second half of the financial year (October to March). Seasonal variance is driven by strong demand from Europe as orders tend to scale up in Oct
Slide 11: Financial Table – Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) 11 (Rs. In crore) Particulars Q3 FY21 Q3 FY20 Growth (%) 9M FY21 9M FY20 Growth (%) Revenue 85.2 82.3 4% 243.7 223.8 9% Expenditure 68.3 66.3 3% 197.9 181.6 9% EBITDA 16.8 16.0 5% 45.8 42.2 9% Margins 19.8% 19.4% 18.8% 18.9% Depreciation 1.8 1.4
Slide 12: Management Commentary
Management Commentary 12 Commenting on the Q3 & 9M FY21 performance, Mr. Haridas Kanani, Chairman & Managing Director, at Neogen Chemicals said: “We have maintained our business momentum in line with our business plan and have demonstrated steady accretion to our earnings. Underlying the growth are
Slide 13: Historical Financial Trends
Historical Financial Trends 13 Net Revenue from Operations** EBITDA (INR crore) Margin (%) (INR crore) 18.1% 17.8% 18.2% 19.0% 15.0% 14.0% 306 239 163 85 101 111 13 14 20 29 43 58 FY15 FY16 FY17 FY18 FY19 FY20 FY15 FY16 FY17 FY18 FY19 FY20 ** Revenue is Net of Excise PAT (INR crore) Margin (%) Netwo
Slide 14: Way Forward
Way Forward 14 Increasing Custom Synthesis & Contract Manufacturing portfolio Augmenting growth in domestic and global markets Expanding production capacities Focus on advanced speciality intermediates Focus on operational efficiency and functional excellence
Slide 15: Contact Us
Contact Us 15 About Neogen Chemicals Limited For further information, please contact: Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is India’s one of the leading manufacturers of Bromine-based and Lithium- Ketan Vyas based specialty chemicals. Neogen Chemicals Ltd.
Slide 16: Thank You
3 ) > x co (ar) = -